Pharma Co. Says PE Firm Owes $6.7M After Merger

Pharma Co. Says PE Firm Owes $6.7M After Merger 180 Life Sciences Corp., a newly minted pharmaceutical company whose work includes cannabinoid research, hit a private equity firm with a breach of contract suit in New York state court on Thursday, alleging it is owed $6.7 million in connection with a merger that closed last year. #CBD #Hemp https://www.law360.com/cannabis/articles/1375737?utm_source=rss&utm_medium=rss&utm_campaign=section April 15, 2021 10:16 pm

Leave Your Reply